Prof Jeffrey Tobias

Prof Jeffrey TobiasTel: 020 3447 9214
Fax: 020 3447 9055
Email: j.tobias@uclh.org

Location:
University College Hospital

Specialities:
Radiotherapy

Professional background

Qualified from Cambridge and St Bartholomew's Hospital 1971. Postgrad posts at UCLH, St Barts, Harvard Med School,  Hammersmith Hospital and the Royal Marsden.  A consultant here since 1981 and Professor of Cancer Medicine since 2002.  MD Thesis  ( Cantab ) 1977.   Author of " Cancer and its Management ", a standard international text, now in its 6th Edn, and six other books,  two for the general public.  Board member of Cancer Research-UK since 1991.  Previous member of the BMJ Ethics Cttee and previous Clinical Director of Oncology at UCLH, 1992- 1998.  Past President of the Brit Assn for Head and Neck Oncology.

Research interests

Breast cancer, myeloma, gynaecological and upper gastro-enterological cancers.

Publications

Multiple papers on innovative techniques of treatment for breast cancer, lung, head and neck and g-i cancers,  ethics of innovative treatments.  Various textbooks.   Fuller listing in " Who's Who "  2010.

Most recent original research papers include :

1.Long-term Results of Targeted Intraoperative Radiotherapy (Targit) Boost during Breast-conserving Surgery.

Vaidya JS, Baum M, Tobias JS,  et al.   Int J Radiat Oncol Biol Phys. 2010 Oct 15. [Epub ahead of print]

2.The ATAC adjuvant breast-cancer trial: six-year results of the endometrial subprotocol.

Duffy S, Jackson TL, Lansdown M, Philips K, Wells M, Clack G, Bianco AR et al, for the ATAC Trialists' Group.
J Obstet Gynaecol. 2010;30(6):596-604.

3.Targeted Intraoperative Radiotherapy for Breast Cancer in Patients in Whom External Beam Radiation Is Not Possible.

Keshtgar MR, Vaidya JS, Tobias JS, et al.  Int J Radiat Oncol Biol Phys. 2010 Jun 18. [Epub ahead of print]

4.Response to "Intraoperative radiotherapy in early-stage breast cancer: results of the Montpellier phase II trial."(Int J Radiat Oncol Biol Phys May 2009).

Vaidya JS, Tobias JS, Baum M, Keshtgar M, Williams N, Wenz F, Joseph D.
Int J Radiat Oncol Biol Phys. 2010 Jul 15;77(4):1289; author reply 1289.

5.Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.

Vaidya JS, Joseph DJ, Tobias JS,  et al.  Lancet. 2010 Jul 10;376(9735):91-102.

6.Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial.

Tobias JS, Monson K, Gupta N, Macdougall H, Glaholm J, Hutchison I, Kadalayil L, Hackshaw A; UK Head and Neck Cancer Trialists' Group.
Lancet Oncol. 2010 Jan;11(1):66-74. Epub 2009 Oct 29.

7.Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Pignon JP, le Maître A, Maillard E, Bourhis J et al for the MACH-NC Collaborative Head and Neck Cancer Group.
Radiother Oncol. 2009 Jul;92(1):4-14. Epub 2009 May 14.

GMC/GDC number: 1505245